Condition: Foot Ulcers, Diabetic · Sponsor: Biotechnology Institute IMASD
This study is a randomized clinical trial that compares the effectiveness of Plasma Rich in Growth Factors (PRGF) with conventional treatment for healing foot ulcers in diabetic patients who also have peripheral arterial disease. The goal is to assess how well PRGF promotes healing over a six-month period.
This description comes directly from the study's public registry record.
Aitana Sainz · +34 945 160 653 · aitana.sainz@bti-implant.es
Always discuss trial participation with your own doctor first.
| Hospital Universitario de Basurto. | Bilbao, Bizkaia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06952998